Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. [PDF]
Blinman P +12 more
europepmc +1 more source
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study). [PDF]
Zurlo IV +10 more
europepmc +1 more source
XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX). [PDF]
Zhu XD +33 more
europepmc +1 more source
Phase II study of perioperative camrelizumab and XELOX for locally advanced gastric or gastroesophageal junction adenocarcinoma. [PDF]
He J +9 more
europepmc +1 more source
CryoEM structural exploration of catalytically active enzyme pyruvate carboxylase. [PDF]
López-Alonso JP +6 more
europepmc +1 more source
Neoadjuvant chemoradiotherapy plus postoperative adjuvant XELOX chemotherapy versus postoperative adjuvant chemotherapy with XELOX regimen for local advanced gastric cancer-A randomized, controlled study. [PDF]
Wang F +8 more
europepmc +1 more source
Pyridoxamine-Oxaloacetic Transaminase of Rat Kidney
H L, WU, M, MASON
openaire +2 more sources
Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer. [PDF]
Bu S +10 more
europepmc +1 more source
Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion. [PDF]
Frégeau-Proulx L +16 more
europepmc +1 more source
Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy. [PDF]
Yun JH, Song GJ, Son MW, Lee MS.
europepmc +1 more source

